CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
NB; DAN; NO3; DAND1; Differential Screening-Selected Gene Aberrant In Neuroblastoma; DAN domain family member 1
- Product No.SCP853Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Test MethodDouble-antibody Sandwich
- Assay Length2h, 40min
- Detection Range27.4-20,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 10.4pg/mL.
- Sample Typetissue homogenates, cell lysates and other biological fluids
- Download Instruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
-
FOB
US$ 588
For more details, please contact local distributors!US$ 840
For more details, please contact local distributors! US$ 3780
For more details, please contact local distributors! US$ 7140
For more details, please contact local distributors! US$ 58800
For more details, please contact local distributors!
Specificity of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
This assay has high sensitivity and excellent specificity for detection of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1).
No significant cross-reactivity or interference between Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) and analogues was observed.
Precision of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Stability of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.
Test principle of the CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1)
The microplate provided in this kit has been pre-coated with an antibody specific to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) level in the sample or standard.;
GIVEAWAYS
INCREMENT SERVICES
Single-component Reagents of Assay Kit
Lysis Buffer Specific for ELISA / CLIA
Quality Control of Kit
CLIA Kit Customized Service
Disease Model Customized Service
Serums Customized Service
TGFB1 Activation Reagent
Real Time PCR Experimental Service
Streptavidin
Fast blue Protein Stain solution
Single-component Reagents of FLIA Kit
Streptavidin-Agarose Beads
Related products
Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
RPP853Hu01 | Recombinant Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAP853Hu01 | Polyclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | WB; IHC; ICC; IP. |
MAP853Hu21 | Monoclonal Antibody to Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | WB; IHC; ICC; IP. |
SEP853Hu | ELISA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCP853Hu | CLIA Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | Chemiluminescent immunoassay for Antigen Detection. |
LMP853Hu | Multiplex Assay Kit for Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
CGP853Hu01 | cDNA of Neuroblastoma, Suppression Of Tumorigenicity 1 (NBL1) | PCR; Protein Expression; etc. |